ATP-dependent K+ channel (KATP) and CFTR Cl- channel blocker. Inhibits KATP currents in the pancreas, causing an increase in intracellular Ca2+ and insulin secretion. Inhibits recombinant CFTR Cl- channels with an IC50 of 20 μM.